AYTU BIOPHARMA, INC Warrants and Rights Outstanding
AYTU BIOPHARMA, INC (AYTU) had Warrants and Rights Outstanding of $400.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2022-05-16
- 2022-03-31: Warrants and Rights Outstanding $400.00K.
- 2022-01-26: Warrants and Rights Outstanding $600.00K.
- 2016-11-30: Warrants and Rights Outstanding $173.00K.
- 2016-05-31: Warrants and Rights Outstanding $20.00K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-16 |
| 2022-01-26 | $600.00K 10-Q · filed 2022-05-16 |
| 2016-11-30 | $173.00K 10-K · filed 2017-08-31 |
| 2016-05-31 | $20.00K 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |